Andrew Witriol
About Andrew Witriol
Andrew Witriol is the Head of U.S. Hematology at Bristol Myers Squibb, with over 20 years of experience in the pharmaceutical and healthcare industry.
Company
Andrew Witriol is currently serving as the Head of U.S. Hematology at Bristol Myers Squibb. With a significant tenure at the company, he has held previous roles including Vice President, Head of U.S. Hematology Marketing, and Vice President, Worldwide Oncology Commercial. His leadership is an integral part of the company's focus on hematology and oncology.
Title
Andrew Witriol holds the title of Head of U.S. Hematology at Bristol Myers Squibb. His role encompasses the leadership and strategic direction of the U.S. Hematology business unit, focusing on sales and marketing efforts to drive growth and innovation in the field.
Education and Expertise
Andrew Witriol has a strong educational background with a Bachelor of Science in Finance from Penn State University and a Master of Business Administration in Marketing from Rutgers University - Newark. His academic achievements have provided a solid foundation for his career in the pharmaceutical and healthcare industry, particularly in finance and marketing.
Professional Background
Andrew Witriol began his career at Accenture, where he spent six years as an Analyst/Consultant. He later joined Bristol-Myers Squibb as an intern, working on marketing strategies for Pravachol and contributing to women's health initiatives at Organon. He transitioned to leadership roles at Bristol Myers Squibb, including Vice President positions in U.S. Hematology Marketing and Worldwide Oncology Commercial before assuming his current role.
Industry Experience
With over 20 years of experience in the pharmaceutical and healthcare industry, Andrew Witriol has developed extensive expertise in both sales and marketing. His career has been marked by key roles and contributions, including leading marketing strategies for major pharmaceutical products and focusing on hematology and oncology at Bristol Myers Squibb.